Jubilant Pharmova Q1 Results

  • BSE: 530019
  • NSE: JUBLPHARMA
  • ISIN: INE700A01033
  • Sector: Biotechnology & Drugs
BSE
7458.10 (1.10%)
Volume8.24 K
Updated: Thu 13 Jun, 2024 | 15:29:20
NSE
74810.85 (1.47%)
Volume3.03 L
Updated: Thu 13 Jun, 2024 | 15:29:55
Today: 736.75
762.70
52-Wk: 319.30
770.65

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jubilant Pharmova Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 23Mar 23QoQ Comp
    Total Revenue 1,586.901,678.00-5.43%
    Selling/ General/ Admin Expenses Total 547.70534.302.51%
    Depreciation/ Amortization 89.70271.23-66.93%
    Other Operating Expenses Total 349.50394.71-11.45%
    Total Operating Expense 1,507.001,730.01-12.89%
    Operating Income 79.90-52.010.00%
    Net Income Before Taxes 25.20-86.410.00%
    Net Income 6.40-97.840.00%
    Diluted Normalized EPS 0.40-6.120.00%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App